A Study of NX-1607 in Adults With Advanced Malignancies

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05107674
Phase: Phase 1
Trial Summary: This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients with advanced malignanci – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Nurix Therapeutics, Inc.
Acronym:

Pin It on Pinterest